Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Histological Techniques × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precancerous Conditions 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Squamous Intraepithelial Lesions 1 Sarcoma 1 Salivary Gland Neoplasms 1 Papillomavirus Infections 1 Multi-centric Castleman's Disease 1 Lymphoma 1 HIV Infections 1 Disease 1 Breast Neoplasms 1 AIDS-related Kaposi sarcoma 1

Interventions

Trastuzumab 623 Paclitaxel 575 Cyclophosphamide 554 Docetaxel 483 Capecitabine 401 Letrozole 372 Fulvestrant 322 Doxorubicin 294 Carboplatin 279 Tamoxifen 272 Anastrozole 240 exemestane 225 Radiotherapy 217 Epirubicin 211 Bevacizumab 196 palbociclib 188 pertuzumab 181 Vinorelbine 167 Lapatinib 167 Gemcitabine 165 pembrolizumab 162 Surveys and Questionnaires 137 Exercise 135 Magnetic Resonance Spectroscopy 123 Fluorouracil 119 eribulin 117 Blood Specimen Collection 117 Albumin-Bound Paclitaxel 117 130-nm albumin-bound paclitaxel 111 Drug Therapy 110

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01668914 2018-04-05

IMSLNB-CANP

Shandong Cancer Hospital and Institute

Phase 3 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡